Literature DB >> 25401513

A categorical structure-activity relationship analysis of GPR119 ligands.

Pritesh Kumar1, Carl A Carrasquer, Arren Carter, Zhao-Hui Song, Albert R Cunningham.   

Abstract

The categorical structure-activity relationship (cat-SAR) expert system has been successfully used in the analysis of chemical compounds that cause toxicity. Herein we describe the use of this fragment-based approach to model ligands for the G protein-coupled receptor 119 (GPR119). Using compounds that are known GPR119 agonists and compounds that we have confirmed experimentally that are not GPR119 agonists, four distinct cat-SAR models were developed. Using a leave-one-out validation routine, the best GPR119 model had an overall concordance of 99%, a sensitivity of 99%, and a specificity of 100%. Our findings from the in-depth fragment analysis of several known GPR119 agonists were consistent with previously reported GPR119 structure-activity relationship (SAR) analyses. Overall, while our results indicate that we have developed a highly predictive cat-SAR model that can be potentially used to rapidly screen for prospective GPR119 ligands, the applicability domain must be taken into consideration. Moreover, our study demonstrates for the first time that the cat-SAR expert system can be used to model G protein-coupled receptor ligands, many of which are important therapeutic agents.

Entities:  

Keywords:  G protein-coupled receptor 119 (GPR119); categorical structure–activity relationship (cat-SAR); diabetes; fragment-based modelling; structure–activity relationship (SAR)

Mesh:

Substances:

Year:  2014        PMID: 25401513      PMCID: PMC4795450          DOI: 10.1080/1062936X.2014.967292

Source DB:  PubMed          Journal:  SAR QSAR Environ Res        ISSN: 1026-776X            Impact factor:   3.000


  24 in total

1.  Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.

Authors:  Graeme Semple; Beatriz Fioravanti; Guillherme Pereira; Imelda Calderon; Jane Uy; Karoline Choi; Yifeng Xiong; Albert Ren; Michael Morgan; Vibha Dave; William Thomsen; David J Unett; Charles Xing; Stuart Bossie; Chris Carroll; Zhi-Liang Chu; Andrew J Grottick; Erin K Hauser; James Leonard; Robert M Jones
Journal:  J Med Chem       Date:  2008-08-13       Impact factor: 7.446

2.  Evaluation of drug interactions of GSK1292263 (a GPR119 agonist) with statins: from in vitro data to clinical study design.

Authors:  Joseph W Polli; Elizabeth Hussey; Mark Bush; Grant Generaux; Glenn Smith; David Collins; Susan McMullen; Nancy Turner; Derek J Nunez
Journal:  Xenobiotica       Date:  2012-12-21       Impact factor: 1.908

3.  Development of an information-intensive structure-activity relationship model and its application to human respiratory chemical sensitizers.

Authors:  A R Cunningham; S L Cunningham; D M Consoer; S T Moss; M H Karol
Journal:  SAR QSAR Environ Res       Date:  2005-06       Impact factor: 3.000

4.  GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms.

Authors:  Grace Flock; Dianne Holland; Yutaka Seino; Daniel J Drucker
Journal:  Endocrinology       Date:  2010-11-10       Impact factor: 4.736

5.  A categorical structure-activity relationship analysis of the developmental toxicity of antithyroid drugs.

Authors:  Albert R Cunningham; C Alex Carrasquer; Donald R Mattison
Journal:  Int J Pediatr Endocrinol       Date:  2010-01-06

Review 6.  Biology of incretins: GLP-1 and GIP.

Authors:  Laurie L Baggio; Daniel J Drucker
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

Review 7.  GPR119 agonists for the treatment of type 2 diabetes.

Authors:  Robert M Jones; James N Leonard; Daniel J Buzard; Juerg Lehmann
Journal:  Expert Opin Ther Pat       Date:  2009-10       Impact factor: 6.674

8.  Structure-activity relationship analysis of rat mammary carcinogens.

Authors:  Albert R Cunningham; Shanna T Moss; Seena A Iype; Gefei Qian; Shahid Qamar; Suzanne L Cunningham
Journal:  Chem Res Toxicol       Date:  2008-08-30       Impact factor: 3.739

9.  Structure-activity relationships of fatty acid amide ligands in activating and desensitizing G protein-coupled receptor 119.

Authors:  Pritesh Kumar; Akhilesh Kumar; Zhao-Hui Song
Journal:  Eur J Pharmacol       Date:  2013-10-30       Impact factor: 4.432

10.  Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.

Authors:  Derek J Nunez; Mark A Bush; David A Collins; Susan L McMullen; Dawn Gillmor; Glen Apseloff; George Atiee; Leonor Corsino; Linda Morrow; Paul L Feldman
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.